- Overseeing and managing the company's business development, marketing, HR, daily operation, R&D and regulatory affairs activities.- Planning the mid-term and long-term strategies.

- Oversaw the research and development activities of ICARES Group.- Brought the Company to IPO in 2018 on TPEx market (Stock ID: 6612).

- Co-founded the Company with two other partners.- Obtained and managed a 3-year R&D funding of a total of USD$3M from the Ministry of Economics (Taiwan) in 2012. Obtained 1 US patent (D789,520) in 2017.- Obtained CE marking for intraocular lens product, aspicio(TM), in 2014.

- A multinational medical device coating company dedicated to development, commercialization and out-licensing of high value-added environmentally friendly coatings.- Managing internal and external R&D innovation programs, commercializing products, and exploring US, European and Asian markets.- Completed 2 licensing deals in 2007, 1 licensing deal in 2009, 1 licensing deal in 2014, 1 licensing deal in 2016 and developed 2 patent applications.- Obtained CE marking and FDA 510(k) approval for intraocular lens injector product, lioliTM IOL Delivery System, in 2014 and 2015, respectively, and CE marking for intraocular lens product, Asqelio(TM), in 2017.

- A multifunctional polymeric materials and membranes company dedicated to the discovery, development and commercialization of high-value materials for multiple industrial applications.- Co-founded the company, raised seed money, completed licensing of 60 patents, made prototypes and filed 14 patents in 3 years.- Raising next round of funding, develop business strategy, establish and oversee R&D programs, commercialize products, and explore US, European and Asian markets.- Published 8 papers and established research collaborations with universities and companies in US, Europe and Japan.- Commercialized the LubriMATRIX(TM) surface treatment technology for making IOL injectors lubricious and autoclavable. The technology was exclusively licensed to AST Products, Inc. Currently treating more than 2 million IOL injectors annually.

Teaching entrepreneurship at the Advanced Graduate Course on Molecular Systems for Devices of Program for Leading Graduate Schools. Mentoring student groups on the creation of business plans for their team projects.

The biggest venture capital firm in Japan with over $2.2 billion in assets. Assisted the Life-Science Team Investment Officer in overseas investment of life science ventures, overseeing due-diligence activities and finalizing investment commitments.Invested in Nereus Pharmaceuticals, Inc., San Diego, CA., and in charge of 12 portfolio US and UK investee companies including Pentose Pharmaceutical (acquired by V.I.Technologies), Inspire Pharmaceuticals (ISPH, IPO@2000/08/03), VascA, NxStage and Lucent Medical Systems.Helped investee companies to explore Japanese and Asian markets.

Member of a team of researchers studying retrovirus-mediated gene therapy.Developed a novel virus separation/purification/eradication device.One technical paper and two issued US patents.

Designed and developed three novel polymer membranes for peritoneal dialysis, polymeric electrolyte fuel cells and water disinfection with partial collaboration from Asahi Chemical Industries Co., Ltd.Managed a 3-year long research project with funding of US$10,000/year on the study of the interaction between microbial cells and polymer brushes.Published 13 papers in world ranked chemical and biotechnological journals, and presented research studies at 4 international and 10 Japanese domestic meetings.

Participated in a national project to develop a system for the recovery of uranium from seawater with a team of 12 researchers from the institute and Japanese firms including IHI Corp., Furukawa Electric Corp., Ebara Research Corp. and Yazaki Corp.Supervised three senior, two Master’s students and one researcher from China on theses and research projects.Instructed a group of 20 researchers from different countries at the UNDP/RCA/IAEA regional training on advanced biomedical applications of radiation technology, and two groups of 20 high school teachers on food sterilization via radiation.